12053606|t|[The role of inflammatory reaction in Alzheimer's disease and neurodegenerative processes].
12053606|a|Recent studies state that specific inflammatory mechanisms contribute to neurodegeneration. The theory is based on laboratory evidence of local upregulation of inflammatory cytokines (ex. IL-1, IL-6), acute phase proteins (ex. alpha 1-antitrypsin), activation of the complement cascade and accumulation of microglia in damaged regions in AD. In addition epidemiologic studies suggest that anti-inflammatory treatment provides some protection from AD. The first trials with prednisone fail to show any positive influence in AD patients. The alternative therapies are now considered with nonsteroid anti-inflammatory drugs, colchicine, cyclophosphamide. The anti-inflammatory treatment gives hope for slowing progression of the disease and decline of AD incidence.
12053606	13	25	inflammatory	Disease	MESH:D007249
12053606	38	57	Alzheimer's disease	Disease	MESH:D000544
12053606	127	139	inflammatory	Disease	MESH:D007249
12053606	165	182	neurodegeneration	Disease	MESH:D019636
12053606	252	264	inflammatory	Disease	MESH:D007249
12053606	280	284	IL-1	Gene	3552
12053606	286	290	IL-6	Gene	3569
12053606	319	338	alpha 1-antitrypsin	Gene	5265
12053606	430	432	AD	Disease	MESH:D000544
12053606	486	498	inflammatory	Disease	MESH:D007249
12053606	539	541	AD	Disease	MESH:D000544
12053606	565	575	prednisone	Chemical	MESH:D011241
12053606	615	617	AD	Disease	MESH:D000544
12053606	618	626	patients	Species	9606
12053606	714	724	colchicine	Chemical	MESH:D003078
12053606	726	742	cyclophosphamide	Chemical	MESH:D003520
12053606	753	765	inflammatory	Disease	MESH:D007249
12053606	841	843	AD	Disease	MESH:D000544
12053606	Association	MESH:D000544	3569
12053606	Association	MESH:D007249	3552
12053606	Association	MESH:D000544	3552
12053606	Association	MESH:D007249	3569
12053606	Negative_Correlation	MESH:D003520	MESH:D000544

